Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000616214 | SCV000722912 | likely benign | not specified | 2017-09-27 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001088173 | SCV001020195 | likely benign | Charcot-Marie-Tooth disease dominant intermediate B | 2025-01-13 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000877456 | SCV001143767 | likely benign | not provided | 2019-08-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002420623 | SCV002721598 | likely benign | Inborn genetic diseases | 2019-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV000877456 | SCV005208233 | likely benign | not provided | criteria provided, single submitter | not provided |